Docobo Unveils Multi-User HealthHUB for Groups of Patients

Docobo, the leading UK manufacturer of telehealth solutions that enables the remote monitoring of patients with long term health conditions such as asthma, COPD, heart disease and hypertension, has unveiled a multi-user version of its HealthHUB portable home monitor. It means that two or more patients can now utilise one device.

With Prime Minister Gordon Brown pledging to offer telehealth services to 100,000 patients, the new HealthHUB is another step by Docobo to bring the benefits of telehealth to people with long term conditions and their carers.

Docobo's widely used HealthHUB enables patients to record vital signs, symptoms, lifestyle and quality of life measures around the clock from any location. This information is then securely transferred to the doc@HOME clinical database that is accessed by clinicians using a standard secure web browser providing a presentation of the patient's health diary and alert indicators.

The introduction of a multi-user device is part of Docobo's long term strategy to develop and produce telehealth technologies that are highly sophisticated yet easy to use.

"It became clear to us that there are clusters of patients, either within the home or where patients are being treated such as in residential homes, who could share a single HealthHUB with multiple log-ins," says Adrian Flowerday, Managing Director of Docobo. "Each patient will still have their own unique pre-recorded settings and each will have their own tests monitored and analysed. The benefit to clinicians is that they needn’t have several devices if one will suffice. These multi-patient systems are ideal for use in residential care homes, homes where more than one person needs to be monitored, or even prison establishments.”

Doc@HOME is a fully versatile system that can be configured to meet the health needs of individual patients; empower patients to participate in their care delivery, support their carers and reduce the burden of care provision through particular information required by clinicians to deliver expert care on a patient by patient basis.

Telehealth solutions enable patients to empower themselves in their own treatment which has other benefits such as cutting down on unnecessary visits to the GP or clinic.

As well as being convenient and easy to use, interactive and personalised software built into the mobile solution means that patients can receive immediate feedback from their clinician after data is entered.

Thousands of patients can be catered for without them having to spend their time visiting the GP's surgery, clinic or hospital. Valuable medical practitioners' time has already been saved by deploying doc@HOME in homes and clinics throughout the UK. Furthermore there have been reductions in out-of-hours calls and unnecessary hospital admissions.

Following on from the launch of a mobile phone device for patients in August 2007, the multi-user HealthHUB is the latest development in Docobo's long term strategy to deliver patient care in a variety of formats based on tried and tested technologies.

Related news article:

About Docobo
Docobo Ltd is the leading UK manufacturer of telehealth solutions involved in the management and prevention of Long Term Conditions (LTCs, also known as chronic diseases). The company is at the forefront of the development of systems for the management of patients with Long Term Conditions in their own homes.

The company has developed a remote monitoring service for LTC's, called doc@HOME®, and is developing a focused range of related services and products to expand its portfolio. This telehealth service offers care providers with an integrated low cost solution for the collection, management and analysis of essential patient related data, and permits efficient interaction between clinicians and patients at home. For further information, please visit www.docobo.co.uk.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...